HOME >> MEDICINE >> NEWS
Study finds continued reduction in breast cancer incidence associated with longer use of raloxifene

Raloxifene (Evista) continues to be associated with more than a 50% reduction in breast cancer incidence beyond the first 4 years of treatment, according to a new study in the December 1 issue of the Journal of the National Cancer Institute.

The randomized, double-blind Multiple Outcomes of Raloxifene Evaluation (MORE) trial found that, in postmenopausal women with osteoporosis, 4 years of treatment with raloxifene was associated with a 72% reduction in breast cancer incidence compared with placebo. The Continuing Outcomes Relevant to Evista (CORE) trial was designed to examine the effect of an additional 4 years of treatment with raloxifene in the same group of women.

In the CORE trial, more than 4,000 women who had been part of the MORE trial continued taking either 60 mg/day of raloxifene, if they had been assigned to the raloxifene group in the MORE trial, or a placebo, if they had been assigned to the placebo group.

Silvana Martino, D.O., of the Cancer Institute Medical Group in Santa Monica, Calif., and colleagues report that, after the 4 years of the CORE trial, incidence of invasive breast cancer for women taking raloxifene was reduced by 59% compared with women taking the placebo, and incidence of estrogen-receptor (ER)-positive invasive breast cancer was reduced by 66%. Over the entire 8 years of MORE and CORE, the incidence of invasive breast cancer and ER-positive invasive breast cancer were reduced by 66% and 76%, respectively. There was no difference between the two groups in incidence of either ER-negative invasive breast cancer or noninvasive breast cancer. In both the MORE and CORE trials, there was a twofold increase in venous thromboembolic events, such as pulmonary embolism, among women taking raloxifene.

"[T]hese data demonstrate that the incidence of ER-positive invasive breast cancer continues to be reduced through 8 years of raloxifene treatment in postmenopausal women with osteoporosis," the authors w
'"/>

Contact: Sarah Zielinski or Kate Travis
jncimedia@oupjournals.org
301-841-1287
Journal of the National Cancer Institute
30-Nov-2004


Page: 1 2

Related medicine news :

1. Study of energy and health in Africa focuses spotlight on charcoal and forest management
2. Study shows promise in identifying kidney failure
3. Study shows patch therapy may be as effective as oral medications
4. Study shows soy is well accepted in school lunches
5. Study finds that coordinating care of chronically ill patients does not increase liability
6. Study provides new estimates of the causes of child mortality worldwide
7. Study finds factors linked to substance use disorder relapse among health care professionals
8. Study finds majority of women willing to accept cervical cancer vaccine for self and children
9. Study shows use of budesonide reduced the risk of asthma related events by 40% in children
10. Study shows risk of cardiac death after radiation for breast cancer has dramatically decreased
11. Study shows acrylamide in baked and fried food does not increase risk of breast cancer in women

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/23/2019)... ... March 22, 2019 , ... Dr. Srini Pillay , ... spent a large chunk of his career subverting ideas on creativity and the processes ... has been a hit since its original release in 2017. Now, the acclaimed doctor ...
(Date:3/20/2019)... ... March 20, 2019 , ... It’s not Easter without the ... the spring holiday season. From April 6 through April 20, the Easter Bunny will ... “Every year, the Bunny Hut brings so much joy to Grossmont Center,” says Trevor ...
(Date:3/20/2019)... ... March 20, 2019 , ... ... paving the way for safe clinical testing. , A recent publication in the ... developed by Nanorx Inc. that has shown promising results for the reversal of ...
(Date:3/20/2019)... ... March 20, 2019 , ... The American Board of Family ... online resource for ABFM Diplomates. The new website, available at http://www.theabfm.org , ... website features a responsive design, providing functional access from a desktop, a tablet, ...
(Date:3/20/2019)... ... 2019 , ... VirtuOx, http://virtuox.net/ , a home respiratory ... cardiac arrhythmias in the patient’s home. , The VirtuOx CardioCHECK program is a ... (MCT) in the convenience and comfort of the patient’s home. , The VirtuOx ...
Breaking Medicine News(10 mins):
(Date:3/20/2019)... ... ... “Some years ago, when I was still a serving military officer, I was ... for the annual competitions of the International Confederation of Reserve Officers, a competition involving ... used to help servicemen prepare for battle and to help wounded veterans in Canada ...
(Date:3/20/2019)... ... 2019 , ... Becker's Hospital Review is pleased to announce ... Conference, held May 2-4 at the Swissotel in Chicago. The celebrity keynotes include:, ... and NFL Legend; ,     Bobbi Brown, Makeup Artist, Author, Entrepreneur and ...
(Date:3/20/2019)... ... March 20, 2019 , ... ... adult residential services’ patients Stay Active & Independent for Life (SAIL). At the ... strength, balance, and fitness can help adults stay active and reduce their chances ...
Breaking Medicine Technology:
Cached News: